Ledger.Open graph →
SEC Form D · Amendment · filed April 22, 2024

Acta Pharmaceuticals, Inc

Offering
$17.5M
Sold
$13.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Rudolph Tanzi · Boston, MADirectorGeorge Alex · Boston, MAExec · DirectorJohn Ackerley · Grand Cayman, Cayman IslandsExec · DirectorJane E. Ingalls · Denver, CODirectorThierry Porte · Boston, MADirectorChristian Carnes · Dover, DEDirectorJack Sunier · Dover, DEExec · DirectorThierry Porte · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗